Novo Nordisk, Eli Lilly fall after Trump comments on weight loss drug pricing
NCR Atleos Corp stock has reached an all-time high, hitting a price of 41.49 USD, with a market capitalization of $2.95 billion. According to InvestingPro analysis, the stock appears slightly undervalued despite trading at a P/E ratio of 23. This milestone reflects a significant upward trend for the company over the past year, during which the stock has seen a remarkable 42.25% increase. The surge to this all-time high underscores the positive investor sentiment and strong market performance that NCR Atleos Corp has experienced, positioning the company as a noteworthy player in its sector. Analyst price targets currently range from $34 to $60, suggesting continued potential upside. For deeper insights and 8 additional key metrics, check out the comprehensive Pro Research Report available on InvestingPro.
In other recent news, NCR Atleos reported its Q2 2025 earnings with an earnings per share (EPS) of $0.93. The company generated revenue of $1.1 billion, which fell short of the $1.15 billion forecast by 4.35%. Despite the revenue miss, the company experienced a surge in stock price, indicating investor optimism. Additionally, the board of directors approved an amendment to the employment agreement of CEO Timothy C. Oliver. This amendment maintains Oliver’s 300% separation multiplier under the Change in Control Severance Plan, which would have otherwise been reduced to 200% by October 16, 2025. These developments are part of NCR Atleos’s ongoing strategic initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.